Adults currently taking GLP‐1 RAs and began taking the medication more than 2 months before screening or currently on an oral diabetes medication and without experience with GLP‐1 RA treatment for T2DM. HCPs were experts in drug development or diabetes/endocrinology. This evidence concerns the gene GCG and type 2 diabetes mellitus.